Everett Harris & Co’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,220
Closed -$211K 272
2021
Q4
$211K Sell
1,220
-1,216
-50% -$185K ﹤0.01% 255
2021
Q3
$354K Sell
2,436
-1,091
-31% -$160K 0.01% 208
2021
Q2
$465K Sell
3,527
-915
-21% -$120K 0.01% 187
2021
Q1
$570K Sell
4,442
-2,196
-33% -$271K 0.01% 165
2020
Q4
$791K Sell
6,638
-19
-0.3% -$2.32K 0.01% 142
2020
Q3
$762K Sell
6,657
-770
-10% -$91K 0.01% 142
2020
Q2
$846K Sell
7,427
-80
-1% -$8.48K 0.02% 130
2020
Q1
$603K Sell
7,507
-241
-3% -$24.9K 0.02% 145
2019
Q4
$827K Buy
7,748
+100
+1% +$10.4K 0.02% 146
2019
Q3
$819K Buy
7,648
+150
+2% +$15.4K 0.02% 139
2019
Q2
$763K Sell
7,498
-150
-2% -$14.4K 0.02% 146
2019
Q1
$688K Buy
7,648
+885
+13% +$76.7K 0.02% 149
2018
Q4
$563K Buy
6,763
+345
+5% +$32.3K 0.02% 151
2018
Q3
$693K Buy
6,418
+2,225
+53% +$244K 0.02% 151
2018
Q2
$461K Buy
4,193
+30
+0.7% +$3.13K 0.01% 174
2018
Q1
$418K Sell
4,163
-30
-0.7% -$3.07K 0.01% 175
2017
Q4
$413K Buy
4,193
+1,590
+61% +$151K 0.01% 179
2017
Q3
$244K Buy
2,603
+225
+9% +$23.9K 0.01% 216
2017
Q2
$264K Buy
2,378
+185
+8% +$19.6K 0.01% 206
2017
Q1
$215K Buy
+2,193
New +$209K 0.01% 220

Other funds holding DGX

Everett Harris & Co's DGX Position: Q1 2022 in Review

Everett Harris & Co sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 1,220 shares — an estimated $211K sold.

Everett Harris & Co first reported a position in DGX in Q1 2017 and held it in 20 quarters. The position peaked at $846K in Q2 2020. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Everett Harris & Co reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Everett Harris & Co sold 1,220 Quest Diagnostics shares in Q1 2022, an estimated $211K.
  • Everett Harris & Co first reported a position in Quest Diagnostics in Q1 2017 and held it in 20 quarters.
  • Everett Harris & Co's Quest Diagnostics position peaked at $846K in Q2 2020.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Everett Harris & Co's 13F filing for Q1 2022, filed 22 Apr 2022.